new glp 1 med is wegovy a glp-1 medication Novo's becomes first drug approved for MASH -1 weight-loss drugs: PA, NJ – GLP-1 Weight Loss Options |

Health records and insurance claims data showed half (n = 85,015) started treatment with GLP-1 receptor agonists between 2013 and 2023

Its sustainable, fat-based loss, not water or muscle

Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function

Clarifying the apicobasal localization of ZIP8, ZIP14, and ZNT10 and understanding their coordinated regulation under Mn deficiency or overload will be critical to delineate how Mn fluxes are maintained during metabolic or inflammatory stress

Cost: These medications can be expensive and may not be covered by all insurance plans, making them financially inaccessible for some individuals

Additionally, on April 30, 2026, per FDA.gov and Federal Register notice 91 Fed